Contemporary Clinical and Molecular Epidemiology of Vancomycin-Resistant Enterococcal Bacteremia: A Prospective Multicenter Cohort Study (VENOUS I)
Authors:
Open Access
- 23 December 2021
- journal article
- research article
- Published by Oxford University Press (OUP) in Open Forum Infectious Diseases
- Vol. 9 (3) , ofab616
Abstract
Vancomycin-resistant enterococci (VRE) are major therapeutic challenges. Prospective contemporary data characterizing the clinical and molecular epidemiology of VRE bloodstream infections (BSIs) are lacking. The Vancomycin-Resistant Enterococcal BSI Outcomes Study (VENOUS I) is a prospective observational cohort of adult patients with enterococcal BSI in 11 US hospitals. We included patients with Enterococcus faecalis or Enterococcus faecium BSI with ≥1 follow-up blood culture(s) within 7 days and availability of isolate(s) for further characterization. The primary study outcome was in-hospital mortality. Secondary outcomes were mortality at days 4, 7, 10, 12, and 15 after index blood culture. A desirability of outcome ranking was constructed to assess the association of vancomycin resistance with outcomes. All index isolates were subjected to whole genome sequencing. Forty-two of 232 (18%) patients died in hospital and 39 (17%) exhibited microbiological failure (lack of clearance in the first 4 days). Neutropenia (hazard ratio [HR], 3.13), microbiological failure (HR, 2.4), VRE BSI (HR, 2.13), use of urinary catheter (HR, 1.85), and Pitt BSI score ≥2 (HR, 1.83) were significant predictors of in-hospital mortality. Microbiological failure was the strongest predictor of in-hospital mortality in patients with E faecium bacteremia (HR, 5.03). The impact of vancomycin resistance on mortality in our cohort changed throughout the course of hospitalization. Enterococcus faecalis sequence type 6 was a predominant multidrug-resistant lineage, whereas a heterogeneous genomic population of E faecium was identified. Failure of early eradication of VRE from the bloodstream is a major factor associated with poor outcomes.Keywords
Funding Information
- National Institute of Allergy and Infectious Diseases (K24AI121296, R01AI134637, R01AI48342,, P01AI152999, UM1AI104681)
- Millennium Science Initiative (MICROB-R, NCN17_081)
- National Institutes of Health (5T32AI055449-15, K01AI148593, T32GM086330, R01AI134637)
This publication has 29 references indexed in Scilit:
- VRE and VSE Bacteremia Outcomes in the Era of Effective VRE Therapy: A Systematic Review and Meta-analysisInfection Control & Hospital Epidemiology, 2015
- Desirability of Outcome Ranking (DOOR) and Response Adjusted for Duration of Antibiotic Risk (RADAR)Clinical Infectious Diseases, 2015
- Trimmomatic: a flexible trimmer for Illumina sequence dataBioinformatics, 2014
- RAxML version 8: a tool for phylogenetic analysis and post-analysis of large phylogeniesBioinformatics, 2014
- Emergence of Epidemic Multidrug-Resistant Enterococcus faecium from Animal and Commensal StrainsmBio, 2013
- SPAdes: A New Genome Assembly Algorithm and Its Applications to Single-Cell SequencingJournal of Computational Biology, 2012
- Molecular Epidemiology of Vancomycin-Resistant Enterococcus faecium : a Prospective, Multicenter Study in South American HospitalsJournal of Clinical Microbiology, 2010
- Bad Bugs, No Drugs: No ESKAPE! An Update from the Infectious Diseases Society of AmericaClinical Infectious Diseases, 2009
- Antimicrobial resistance and molecular epidemiology of vancomycin-resistant enterococci from North America and Europe: a report from the SENTRY antimicrobial surveillance programDiagnostic Microbiology and Infectious Disease, 2007
- Molecular epidemiology of vancomycin-resistant Enterococcus faecium in ArgentinaInternational Journal of Infectious Diseases, 2007